Trends Paving The Way For An Influx Of Biosimilar Development

Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With many patents for blockbuster” commercial biologics set to expire in the next few years, biopharma developers have become increasingly drawn to the biosimilars market.

Click for full article

Featured Expert

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles